Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Lindblad Expeditions Holdings, Inc. Q1 2026 Earnings Call - Record Yields and Booking Momentum Defy Geopolitical Headwinds
Lindblad Expeditions delivered another record quarter despite severe weather disruptions in Antarctica and geopolitical fallout from the war in Iran. The company achieved a historic 93% first quarter ...
- Record Q1 occupancy of 93% on 6% capacity growth, driving a 7% net yield increase to $1,631 per available guest night.
- Total revenues grew 16% to $208 million, with Lindblad segment up 16% and Land Experiences up 14%.
- Adjusted EBITDA rose 16% to $34.8 million, while net income turned positive at $6 million compared to a loss last year.
- +12 more takeaways
Metallus Q1 2026 Earnings Call - Defense Run Rate and Tariff Tailwinds Drive Profitability
Metallus delivered a strong first quarter in 2026, with adjusted EBITDA rising 39% year-over-year to $24.6 million and shipments climbing 11% sequentially. The growth was fueled by a robust order book...
- Adjusted EBITDA surged 39% year-over-year to $24.6 million, driven by higher shipments, improved price mix, and better raw material spreads.
- Net sales reached $308.3 million, a 10% increase year-over-year, with shipments up 11% sequentially across most end markets.
- Order book grew significantly year-over-year, with lead times expanding into the late third quarter for bars and seamless mechanical tubing, signaling strong demand momentum.
- +7 more takeaways
IDEXX Laboratories Q1 2026 Earnings Call - IDEXX Raises Full-Year Guidance on CAG Diagnostics Growth and InViewDX Momentum
IDEXX Laboratories delivered a strong start to 2026, driving a full-year revenue and EPS guidance raise fueled by double-digit organic growth in companion animal diagnostics and robust international e...
- Full-year revenue guidance raised to $4.675B-$4.760B, reflecting an 8.6%-10.6% reported growth range and a $32M midpoint improvement.
- Full-year EPS guidance increased to $14.45-$14.90, up $0.13 at midpoint, driven by operational performance and margin expansion.
- Q1 2026 organic revenue grew 11%, with CAG Diagnostics recurring revenue up 11% organically, supported by 11% U.S. and 12% international growth.
- +9 more takeaways
Waters Corporation Q1 2026 Earnings Call - Raised Full-Year Guidance on Synergy Execution and Acquired Business Turnaround
Waters Corporation delivered a strong first quarter of 2026, combining double-digit organic growth in its legacy business with a significant turnaround in its newly acquired BD Biosciences and Diagnos...
- Total reported revenue reached $1.267 billion, with organic revenue growing 13% as reported (11% constant currency), beating the high end of guidance by 200 basis points.
- Adjusted EPS grew 20% year-over-year to $2.70, exceeding the high end of the guidance range by $0.35, driven by top-line strength and disciplined cost management.
- The acquired BD Biosciences and Diagnostic Solutions businesses delivered $520 million in revenue, beating guidance by $40 million and showing estimated as-reported growth of 7%.
- +7 more takeaways
IAC Q1 2026 Earnings Call - IAC Renames to People Inc. as Core Publishing Business Accelerates Non-Session Revenue Growth
IAC delivered a solid first quarter, with People Inc. digital revenue up 8% and digital adjusted EBITDA margins expanding to 20%. The company is aggressively pivoting away from traditional web session...
- IAC digital revenue grew 8% in Q1 2026, marking the 10th consecutive quarter of growth, while digital adjusted EBITDA margins expanded to 20% from 18% year-over-year.
- Non-session-based revenue surged 24% year-over-year, now representing 41% of People Inc. digital revenue, driven by AI targeting, social programs, Apple News, and licensing deals.
- IAC announced it will rebrand as People Incorporated, consolidating corporate functions and eliminating the duplicate IAC parent layer to generate $40 million in annual run-rate savings.
- +7 more takeaways
Rockwell Automation Q2 FY2026 Earnings Call - Data Center & Warehouse Automation Drive Double-Digit Growth
Rockwell Automation delivered a standout second quarter in fiscal 2026, with organic sales growing 9% and adjusted EPS jumping 30% to $3.30, significantly beating expectations. The growth was broad-ba...
- Organic sales grew 9% year-over-year, with reported sales up 12%, driven by strong performance across multiple end markets and favorable currency translation contributing 3 points.
- Adjusted EPS surged 30% to $3.30, beating expectations, supported by higher volume, positive price-cost dynamics, favorable mix, and productivity gains.
- Data center sales more than doubled year-over-year, emerging as one of the strongest end markets, driven by demand for industrial-grade controllers and power distribution solutions.
- +9 more takeaways
GLOBALFOUNDRIES Q1 2026 Earnings Call - Margin Expansion and Optical Networking Momentum Drive Transformation
GlobalFoundries delivered a strong first quarter 2026, beating guidance across all non-IFRS profitability metrics. Revenue of $1.634 billion was up 3.1% year-over-year, driven by double-digit growth i...
- GlobalFoundries reported Q1 2026 revenue of $1.634 billion, up 3.1% year-over-year and at the high end of guidance, driven by strong performance in automotive and data center segments.
- Gross margin expanded 510 basis points year-over-year to 29%, marking the largest improvement in three years, supported by a favorable product mix shift and cost synergies from the Advanced Micro Foundry acquisition.
- Technology services revenue grew to 13% of total revenue, exceeding the high end of the guided range, with the MIPS acquisition and upcoming Synopsys ARC IP deal expected to further boost this high-margin segment.
- +7 more takeaways
CPI Card Group Q1 2026 Earnings Call - Revenue Surges 20% on Arroweye, Prepaid Weakness and Tariffs Weigh on Margins
CPI Card Group kicked off 2026 with a 20% revenue jump to $147 million, driven by a $16 million contribution from its Arroweye acquisition and strong contactless card demand. The secure card solutions...
- Revenue surged 20% year-over-year to $147 million, beating expectations and driven by a $16 million contribution from the Arroweye acquisition.
- Secure card solutions revenue jumped 35%, fueled by strong contactless card demand and increased personalization services.
- Prepaid solutions revenue declined 17% due to order timing and a transitional market as customers evaluate chip and digital security upgrades.
- +7 more takeaways
Pediatrix Medical Group Q1 2026 Earnings Call - Strong Pricing Outpaces Volume Declines, Full-Year Outlook Reaffirmed
Pediatrix Medical Group delivered a robust first quarter, driven by pricing strength that more than offset modest volume declines across service lines. Adjusted EBITDA came in at $58 million, supporte...
- Adjusted EBITDA reached $58 million in Q1 2026, exceeding expectations and reflecting strong top-line growth despite modest volume declines.
- Pricing growth of 4% outpaced same-unit volume growth of just under 3%, driven by robust revenue cycle management collections, favorable payer mix, increased neonatal acuity, and higher contract administrative fees.
- Full-year 2026 adjusted EBITDA guidance of $280 million to $300 million was reaffirmed, with management expressing confidence in the outlook despite potential macroeconomic headwinds.
- +7 more takeaways
"Surgery Partners" Q1 2026 Earnings Call - Margin Headwinds Offset by Strong Robotics and Physician Growth
Surgery Partners delivered a steady start to 2026, posting $811 million in net revenue and $102 million in adjusted EBITDA that tracked closely with internal expectations. While same-facility case gro...
- First quarter net revenue reached approximately $811 million, while adjusted EBITDA came in at $102 million, landing in line with internal expectations.
- Same-facility revenue growth accelerated to 4.4%, outpacing the modest 0.6% same-facility case growth, highlighting a successful shift toward higher-acuity procedures.
- Weather-related disruptions in January and February temporarily deflected lower-acuity cases, particularly in GI and ophthalmology, impacting case growth by roughly 40 basis points.
- +9 more takeaways